FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2020494673> ?p ?o ?g. }

• W2020494673 endingPage "735" @default.
• W2020494673 startingPage "729" @default.
• W2020494673 abstract "Background/Aims This study sought to identify the independent risk factors involved in the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection who have normal alanine aminotransferase (ALT) levels. Methods A total of 519 patients with average ALT integration values less than or equal to 40 IU/L over 10 years were included. Baseline ultrasound was done in all patients and 68 patients underwent liver biopsy at the start of this study. Factors associated with the cumulative incidence of HCC were determined. Results HCC occurred in 48 of 519 patients (9.2%). The following factors were significantly associated with the incidence of HCC: age > 65 years (adjusted hazard ratio: 2.006 [95% confidence interval: 1.078–3.733]), ALT > 20 IU/L (6.242 [1.499–25.987]), platelet count < 15.0 × 104/m3 (2.675 [1.407–5.085]), total bilirubin > 1.2 mg/dL (2.798 [1.257–6.228]), ALP > 338 IU/L (2.486 [1.327–4.657]), and total albumin < 3.5 g/dl (2.707 [1.177–6.223]). The 5- and 10-year cumulative incidences of HCC were 4.4% and 26.5% in patients with ALT > 20 IU/L and platelet count < 15.0 × 104/m3, respectively. Conclusions High ALT level and low platelet count are closely associated with the development of hepatocarcinogenesis. Therefore, individuals within this group are candidates for antiviral therapy. This study sought to identify the independent risk factors involved in the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV) infection who have normal alanine aminotransferase (ALT) levels. A total of 519 patients with average ALT integration values less than or equal to 40 IU/L over 10 years were included. Baseline ultrasound was done in all patients and 68 patients underwent liver biopsy at the start of this study. Factors associated with the cumulative incidence of HCC were determined. HCC occurred in 48 of 519 patients (9.2%). The following factors were significantly associated with the incidence of HCC: age > 65 years (adjusted hazard ratio: 2.006 [95% confidence interval: 1.078–3.733]), ALT > 20 IU/L (6.242 [1.499–25.987]), platelet count < 15.0 × 104/m3 (2.675 [1.407–5.085]), total bilirubin > 1.2 mg/dL (2.798 [1.257–6.228]), ALP > 338 IU/L (2.486 [1.327–4.657]), and total albumin < 3.5 g/dl (2.707 [1.177–6.223]). The 5- and 10-year cumulative incidences of HCC were 4.4% and 26.5% in patients with ALT > 20 IU/L and platelet count < 15.0 × 104/m3, respectively. High ALT level and low platelet count are closely associated with the development of hepatocarcinogenesis. Therefore, individuals within this group are candidates for antiviral therapy." @default.
• W2020494673 created "2016-06-24" @default.
• W2020494673 creator A5000858203 @default.
• W2020494673 creator A5008619085 @default.
• W2020494673 creator A5010212579 @default.
• W2020494673 creator A5017515823 @default.
• W2020494673 creator A5026964230 @default.
• W2020494673 creator A5027001120 @default.
• W2020494673 creator A5039688182 @default.
• W2020494673 creator A5043762552 @default.
• W2020494673 creator A5047337502 @default.
• W2020494673 creator A5064636550 @default.
• W2020494673 creator A5081418955 @default.
• W2020494673 creator A5085254434 @default.
• W2020494673 date "2009-04-01" @default.
• W2020494673 modified "2023-10-18" @default.
• W2020494673 title "Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels" @default.
• W2020494673 cites W101685149 @default.
• W2020494673 cites W1605260062 @default.
• W2020494673 cites W1931225762 @default.
• W2020494673 cites W1968285537 @default.
• W2020494673 cites W1970758225 @default.
• W2020494673 cites W1993150068 @default.
• W2020494673 cites W2000494728 @default.
• W2020494673 cites W2004350674 @default.
• W2020494673 cites W2007545092 @default.
• W2020494673 cites W2016940072 @default.
• W2020494673 cites W2033142105 @default.
• W2020494673 cites W2044328119 @default.
• W2020494673 cites W2079434996 @default.
• W2020494673 cites W2079486877 @default.
• W2020494673 cites W2088053309 @default.
• W2020494673 cites W2108361563 @default.
• W2020494673 cites W2116460737 @default.
• W2020494673 cites W2159954692 @default.
• W2020494673 cites W2167596859 @default.
• W2020494673 cites W2171191174 @default.
• W2020494673 cites W4239108047 @default.
• W2020494673 cites W4246506823 @default.
• W2020494673 cites W4247791694 @default.
• W2020494673 cites W4368139603 @default.
• W2020494673 doi "https://doi.org/10.1016/j.jhep.2008.11.019" @default.
• W2020494673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19232448" @default.
• W2020494673 hasPublicationYear "2009" @default.
• W2020494673 type Work @default.
• W2020494673 sameAs 2020494673 @default.
• W2020494673 citedByCount "46" @default.
• W2020494673 countsByYear W20204946732012 @default.
• W2020494673 countsByYear W20204946732013 @default.
• W2020494673 countsByYear W20204946732014 @default.
• W2020494673 countsByYear W20204946732015 @default.
• W2020494673 countsByYear W20204946732016 @default.
• W2020494673 countsByYear W20204946732017 @default.
• W2020494673 countsByYear W20204946732019 @default.
• W2020494673 countsByYear W20204946732020 @default.
• W2020494673 countsByYear W20204946732021 @default.
• W2020494673 countsByYear W20204946732022 @default.
• W2020494673 crossrefType "journal-article" @default.
• W2020494673 hasAuthorship W2020494673A5000858203 @default.
• W2020494673 hasAuthorship W2020494673A5008619085 @default.
• W2020494673 hasAuthorship W2020494673A5010212579 @default.
• W2020494673 hasAuthorship W2020494673A5017515823 @default.
• W2020494673 hasAuthorship W2020494673A5026964230 @default.
• W2020494673 hasAuthorship W2020494673A5027001120 @default.
• W2020494673 hasAuthorship W2020494673A5039688182 @default.
• W2020494673 hasAuthorship W2020494673A5043762552 @default.
• W2020494673 hasAuthorship W2020494673A5047337502 @default.
• W2020494673 hasAuthorship W2020494673A5064636550 @default.
• W2020494673 hasAuthorship W2020494673A5081418955 @default.
• W2020494673 hasAuthorship W2020494673A5085254434 @default.
• W2020494673 hasConcept C120665830 @default.
• W2020494673 hasConcept C121332964 @default.
• W2020494673 hasConcept C126322002 @default.
• W2020494673 hasConcept C207103383 @default.
• W2020494673 hasConcept C2777513400 @default.
• W2020494673 hasConcept C2778019345 @default.
• W2020494673 hasConcept C2778606649 @default.
• W2020494673 hasConcept C2780434524 @default.
• W2020494673 hasConcept C2911091166 @default.
• W2020494673 hasConcept C2992872382 @default.
• W2020494673 hasConcept C44249647 @default.
• W2020494673 hasConcept C61511704 @default.
• W2020494673 hasConcept C71924100 @default.
• W2020494673 hasConcept C88879693 @default.
• W2020494673 hasConcept C89560881 @default.
• W2020494673 hasConcept C90924648 @default.
• W2020494673 hasConceptScore W2020494673C120665830 @default.
• W2020494673 hasConceptScore W2020494673C121332964 @default.
• W2020494673 hasConceptScore W2020494673C126322002 @default.
• W2020494673 hasConceptScore W2020494673C207103383 @default.
• W2020494673 hasConceptScore W2020494673C2777513400 @default.
• W2020494673 hasConceptScore W2020494673C2778019345 @default.
• W2020494673 hasConceptScore W2020494673C2778606649 @default.
• W2020494673 hasConceptScore W2020494673C2780434524 @default.
• W2020494673 hasConceptScore W2020494673C2911091166 @default.
• W2020494673 hasConceptScore W2020494673C2992872382 @default.
• W2020494673 hasConceptScore W2020494673C44249647 @default.
• W2020494673 hasConceptScore W2020494673C61511704 @default.

• next